Using the consolidated framework for implementation research to evaluate facilitators and barriers to early outpatient specialty palliative care in patients with advanced cancer.

Authors

null

Rachel E Rosenblum

Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

Rachel E Rosenblum , Carolyn Impagliazzo , Lindsay B. Abdulhay , Elyse R. Park , Shari S. Rogal , Jennifer S. Temel , Robert M Arnold , Yael Schenker

Organizations

Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh Medical Center, Pittsburgh, PA, Department of Psychiatry and Medicine, Massachusetts General Hospital, Boston, MA, Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, Palliative Research Center (PaRC) and Department of Medicine, Division of General Internal Medicine, Section of Palliative Care and Medical Ethics, University of Pittsburgh, Pittsburgh, PA

Research Funding

Other Foundation

Background: Prior studies have shown that integration of early outpatient specialty palliative care (OSPC) with oncologic care improves patient’s symptom burden and quality of life. As a result, the American Society of Clinical Oncology (ASCO) recommends that OSPC be offered within 8 weeks of diagnosis of an advanced solid malignancy. Over the past decade, there has been an increase in the availability of OSPC services, particularly at National Cancer Institute (NCI)-designated cancer centers; however, the majority of OSPC referrals still occur late in the disease course. The aim of this study was to evaluate the facilitators and barriers to implementation of early OSPC. Methods: To assess the contextual determinants of early OSPC implementation, we developed a survey based on constructs from the Consolidated Framework for Implementation Research (CFIR), an implementation meta-framework. Using input from subject-matter experts, we tailored the survey to include a total of 18 relevant constructs from the 5 CFIR domains. The survey was distributed to the ambulatory palliative care (PC) clinical leader at NCI-designated cancer centers. The survey assessed each CFIR construct using a 5-point Likert Scale, where +2 represented the strongest facilitators, and -2 represented the strongest barriers. We inquired about respondent sociodemographics and OSPC clinic characteristics and used descriptive statistics to summarize responses to survey items. Results: Survey responses were collected between 12/15/21 and 1/18/22. Of the 63 NCI-designated cancer centers invited to participate, 40 (63%) completed the survey, while 3 (5%) did not due to not having an ambulatory program. All respondents were physicians. Half of the OSPC clinics were established for more than 10 years, and the majority (75%) provided care to more than 300 distinct outpatients annually. The most commonly agreed upon facilitators (Likert score = 1 or 2) to early OSPC included PC clinicians’ awareness of the ASCO recommendation for early OSPC (100%), informal communication between PC and oncology clinicians (100%), PC clinicians’ belief that OSPC improves the quality of oncology care (100%) and access to telemedicine (93%). The most commonly agreed upon barriers (Likert score = -1 or -2) included inadequate number of OSPC providers (73%) and lack of performance metric goals relating to early OSPC set by PC leadership (65%). Conclusions: Although OSPC clinics at NCI-designated cancer centers have grown over the last ten years, the utilization of early OSPC is impacted by the implementing institution’s resource availability, interdepartmental communication, stakeholder beliefs, and leadership engagement. Future studies should compare the barriers and facilitators of early OSPC identified by PC clinicians and oncologists to inform implementation strategies.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12105)

DOI

10.1200/JCO.2022.40.16_suppl.12105

Abstract #

12105

Poster Bd #

350

Abstract Disclosures

Similar Abstracts

First Author: Tara L. Kaufmann

First Author: Anjali Goyal